Virusight Diagnostic
Virusight Diagnostic is a joint venture between Newsight Imaging and ARC, the medical innovation arm of Sheba Medical Center. The company develops revolutionary rapid-testing solutions based on Spectral technology and AI, providing a digital healthcare platform for immediate detection of various pathogens and diseases. Their mission is to provide portable, immediate, and affordable diagnostic solutions everywhere, enabling ultra-fast, accurate, and non-invasive testing, especially for COVID-19.
Industries
Nr. of Employees
small (1-50)
Products
Portable miniaturized spectrophotometer device
A compact, low-cost spectrometer device that accepts cuvette samples and acquires spectral images of oral swab samples for immediate analysis; designed for point-of-care use and mass screening.
AI-based diagnostic application and cloud platform
Cloud-connected diagnostic software and client application that analyzes spectral data (locally or via cloud), returns a classification result in real time, and provides analytics dashboards for monitoring.
Integrated rapid pathogen diagnostic system
Combined offering comprising the portable spectrometer device, reagent-based cuvette sample preparation, and AI/cloud software to deliver a point-of-care pathogen test with reported clinical performance (reported overall accuracy 96.3% vs RT‑PCR in a study of >550 samples).
SpectraLIT
SpectraLIT is the first portable, affordable, and easy-to-use spectrometer on the market, combining a miniaturized photo spectrometer on a chip with AI-based algorithms and cloud connectivity for real-time diagnostic testing.
Virusight Pathogen Diagnostic Solution
An affordable, ultra-rapid point-of-care pathogen diagnostic solution that delivers results within 20 seconds by combining artificial intelligence with spectral acquisition.
Virusight's App
User-friendly, AI-based cloud software for instant detection of different diseases, providing immediate results and improving accuracy over time using big data and machine learning.
Portable miniaturized spectrophotometer device
A compact, low-cost spectrometer device that accepts cuvette samples and acquires spectral images of oral swab samples for immediate analysis; designed for point-of-care use and mass screening.
AI-based diagnostic application and cloud platform
Cloud-connected diagnostic software and client application that analyzes spectral data (locally or via cloud), returns a classification result in real time, and provides analytics dashboards for monitoring.
Integrated rapid pathogen diagnostic system
Combined offering comprising the portable spectrometer device, reagent-based cuvette sample preparation, and AI/cloud software to deliver a point-of-care pathogen test with reported clinical performance (reported overall accuracy 96.3% vs RT‑PCR in a study of >550 samples).
SpectraLIT
SpectraLIT is the first portable, affordable, and easy-to-use spectrometer on the market, combining a miniaturized photo spectrometer on a chip with AI-based algorithms and cloud connectivity for real-time diagnostic testing.
Virusight Pathogen Diagnostic Solution
An affordable, ultra-rapid point-of-care pathogen diagnostic solution that delivers results within 20 seconds by combining artificial intelligence with spectral acquisition.
Virusight's App
User-friendly, AI-based cloud software for instant detection of different diseases, providing immediate results and improving accuracy over time using big data and machine learning.
Services
Cloud-hosted dashboards and online analytics for monitoring infection points and reporting to health authorities; delivered on-demand to end users.
Cloud-hosted dashboards and online analytics for monitoring infection points and reporting to health authorities; delivered on-demand to end users.
Expertise Areas
- Spectral-based pathogen diagnostics
- Point-of-care rapid diagnostic workflows
- AI and machine learning for diagnostic classification
- Miniaturized spectrometer and sensor development
Key Technologies
- Spectral photometry / spectroscopy
- Miniaturized spectrometer-on-chip (CMOS-based)
- Machine learning / AI classification models
- Cloud-based analytics and dashboards
News & Updates
A clinical study of over 550 samples conducted in Italy delivered 92.7% sensitivity and 96.8% specificity, demonstrating the effectiveness of Virusight’s SpectraLIT® in detecting COVID-19 in less than 20 seconds.
Following COVID-19 success, Virusight and Technogenetics signed a Memorandum of Understanding to develop new spectral-based pathogen diagnostics for global deployment.
Tested on 550 saliva samples, Virusight’s device was found to be safe and effective at detecting COVID-19 rapidly.
Virusight was recognized for its innovative AI and spectral technology for pathogen detection.
SpectraLIT, a rapid pathogen diagnostic device, is undergoing MHRA registration for approval.
A clinical study of over 550 samples conducted in Italy delivered 92.7% sensitivity and 96.8% specificity, demonstrating the effectiveness of Virusight’s SpectraLIT® in detecting COVID-19 in less than 20 seconds.
Following COVID-19 success, Virusight and Technogenetics signed a Memorandum of Understanding to develop new spectral-based pathogen diagnostics for global deployment.
Tested on 550 saliva samples, Virusight’s device was found to be safe and effective at detecting COVID-19 rapidly.
Virusight was recognized for its innovative AI and spectral technology for pathogen detection.
SpectraLIT, a rapid pathogen diagnostic device, is undergoing MHRA registration for approval.